HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,152,000 | -13.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $1,331,000 | +65.3% | 10,000 | 0.0% | 0.00% | – |
| Q4 2015 | $805,000 | -52.8% | 10,000 | 0.0% | 0.00% | – |
| Q3 2015 | $1,705,000 | -16.6% | 10,000 | 0.0% | 0.00% | – |
| Q2 2015 | $2,045,000 | -10.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2015 | $2,280,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT, INC | 803,283 | $189,000 | 0.00% |
| Joel Isaacson & Co., LLC | 30,500 | $7,000 | 0.00% |
| Investors Capital Advisory Services | 17,000 | $3,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 288,100 | $68,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,900 | $7,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,396 | $2,000 | 0.00% |
| NORTHERN TRUST CORP | 242,576 | $57,000 | 0.00% |
| CITIGROUP INC | 1,019 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 21,295 | $5,000 | 0.00% |
| UBS AG | 10,110 | $2,000 | 0.00% |